Abstract
Reducing procedural discomfort for children requiring respiratory testing for SARS-CoV-2 is important in supporting testing strategies for case identification. Alternative sampling methods to nose and throat swabs, which can be self-collected, may reduce laboratory-based testing requirements and provide rapid results for clearance to attend school or hospital settings. The aim of this study was to compare preference and diagnostic sensitivity of a novel anterior nasal swab (ANS), and saliva, with a standard combined nose and throat (CTN) swab. The three samples were self-collected by children aged 5-18 years who had COVID-19 or were a household close contact. Samples were analysed by reverse transcription polymerase chain reaction (RT-PCR) on the Allplex SARS-CoV-2 Assay. Most children and parents preferred the ANS and saliva swab over the CTN swab for future testing. The ANS was highly sensitive (sensitivity 1.000 (95% Confidence Interval (CI) 0.920, 1.000)) for SARS-CoV-2 detection, compared to saliva (sensitivity 0.886, 95% CI 0.754, 0.962). We conclude the novel ANS is a highly sensitive and more comfortable method for SARS-CoV-2 detection when compared to CTN swab.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT05043623
Funding Statement
This work was supported by a grant from Rhinomed Pty Ltd and the Victorian Department of Jobs, Precincts and Regions.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval was by The Royal Children's Hospital Human Research Ethics Committee (HREC77305)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of Interest: The authors have no conflicts of interest relevant to this article to disclose
Funding: This work was supported by a grant from Rhinomed Pty Ltd and the Victorian Department of Jobs, Precincts and Regions.
Role of Funder: The funding sources had no role in the design of this study, its execution, analyses, interpretation of the data, or decision to submit results for publication.
Clinical Trial Registration: ClinicalTrials.gov ID NCT05043623
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- ANS
- Anterior Nasal Swab
- COVID-19
- Coronavirus disease 2019
- CTN
- Combined Throat and Nose Swab
- RT-PCR
- Reverse transcription polymerase chain reaction
- SARS-CoV-2
- severe acute respiratory syndrome coronavirus 2
